Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3145510 | 0.82 | ALDH1A1 (0.42) | ALDH1A1TSHRFOLH1ALOX15CES2 | |
| SCHEMBL152624 | 0.80 | ALDH1A1 (0.50) | ALDH1A1TSHRFOLH1ALOX15CES2 | |
| SCHEMBL602386 | 0.80 | FOLH1 (0.59) | ALDH1A1TSHRFOLH1ALOX15HPGD | |
| SCHEMBL873231 | 0.80 | HPGD (0.52) | ALDH1A1TSHRFOLH1ALOX15L3MBTL1 | |
| SCHEMBL4261085 | 0.80 | GABRA1 (0.44) | ALDH1A1TSHRFOLH1L3MBTL1HPGD | |
| SCHEMBL1004137 | 0.78 | KDM4E (0.50) | ALDH1A1TSHRL3MBTL1HPGDKDM4E | |
| Hydrochloric Acid SCHEMBL3624217 | 0.78 | FOLH1 (0.57) | ALDH1A1TSHRFOLH1ALOX15HPGD | |
| SCHEMBL11359573 | 0.78 | ALDH1A1 (0.39) | ALDH1A1TSHRFOLH1ALOX15CES2 | |
| SCHEMBL11754245 | 0.78 | FOLH1 (0.42) | ALDH1A1TSHRFOLH1ALOX15CES2 | |
| SCHEMBL11721016 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TSHRFOLH1ALOX15CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8729307-B2 | Photoresponsive ionic organic compound, method of producing the same, and photoresponsive carbon nanotube dispersant comprising said ionic organic compound | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2014-05-20 | — | — | US | claimed |
| US-20120217151-A1 | PHOTORESPONSIVE IONIC ORGANIC COMPOUND, METHOD OF PRODUCING THE SAME, AND PHOTORESPONSIVE CARBON NANOTUBE DISPERSANT COMPRISING SAID IONIC ORGANIC COMPOUND | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2012-08-30 | — | — | US | claimed |
| US-6004536-A | USED FOR STAINING MEMBRANES IN CELLS OR ISOLATED FROM CELLS, ARE WELL-RETAINED THEREIN | MOLECULAR PROBES, INC. (US) | 1999-12-21 | — | — | US | claimed |
| CN-113207298-B | Technique for preparing myocardial cell aggregate for improving survival rate under freezing preservation and hypoxia condition | T&R碧欧法博有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20220119769-A1 | FABRICATION TECHNIQUE FOR CARDIOMYOCYTE CLUSTER WITH IMPROVED VIABILITY IN CRYOPRESERVATION AND HYPOXIC CONDITION | T&R BIOFAB CO., LTD. (KR) | 2022-04-21 | — | — | US | disclosed |
| WO-2021112374-A1 | CARDIOMYOCYTE AGGREGATE PRODUCTION TECHNIQUE IMPROVING SURVIVAL RATE UNDER CRYOPRESERVATION AND HYPOXIC CONDITIONS | 주식회사 티앤알바이오팹 | 2021-06-10 | — | — | WO | disclosed |
| US-8729307-B2 | Photoresponsive ionic organic compound, method of producing the same, and photoresponsive carbon nanotube dispersant comprising said ionic organic compound | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2014-05-20 | — | — | US | disclosed |
| US-8535941-B2 | Lipophilic dye-based FRET assays for clostridial toxin activity | ALLERGAN, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-20120231538-A1 | LIPOPHILIC DYE-BASED FRET ASSAYS FOR CLOSTRIDIAL TOXIN ACTIVITY | ALLERGAN, INC. (US) | 2012-09-13 | — | — | US | disclosed |
| US-20120217151-A1 | PHOTORESPONSIVE IONIC ORGANIC COMPOUND, METHOD OF PRODUCING THE SAME, AND PHOTORESPONSIVE CARBON NANOTUBE DISPERSANT COMPRISING SAID IONIC ORGANIC COMPOUND | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2012-08-30 | — | — | US | disclosed |
| US-8124357-B2 | Cell comprising exogenous clostridial toxin receptor for use as quality control agents in pharmaceutical and food processing | ALLERGAN, INC. (US) | 2012-02-28 | — | — | US | disclosed |
| EP-2293064-A1 | Lipophilic dye-based FRET assays for clostridial toxin activity | ALLERGAN, INC. (US) | 2011-03-09 | — | — | EP | disclosed |
| EP-1869459-B1 | LIPOPHILIC DYE-BASED FRET ASSAYS FOR CLOSTRIDIAL TOXIN ACTIVITY | ALLERGAN INC (US) | 2010-06-09 | — | — | EP | disclosed |
| US-20080160561-A1 | Lipophilic Dye-Based Fret Assays for Clostridal Toxin Activity | ALLERGAN INC. (US) | 2008-07-03 | — | — | US | disclosed |
| EP-1869459-A2 | LIPOPHILIC DYE-BASED FRET ASSAYS FOR CLOSTRIDIAL TOXIN ACTIVITY | Allergan, Inc. (US) | 2007-12-26 | — | — | EP | disclosed |
| EP-1843160-A1 | Simultaneous determination of forward and reverse abo blood group | ORTHO-CLINICAL DIAGNOSTICS, INC. (US) | 2007-10-10 | — | — | EP | disclosed |
| WO-2006107921-A2 | LIPOPHILIC DYE-BASED FRET ASSAYS FOR CLOSTRIDIAL TOXIN ACTIVITY | ALLERGAN, INC. (US) | 2006-10-12 | — | — | WO | disclosed |
| US-6955889-B1 | Simultaneous determination of forward and reverse ABO blood group | ORTHO-CLINICAL DIAGNOSTICS, INC. (US) | 2005-10-18 | — | — | US | disclosed |
| EP-1059534-A2 | Simultaneous determination of forward and reverse ABO blood group | Ortho-Clinical Diagnostics, Inc. (US) | 2000-12-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120217151-A1 | PHOTORESPONSIVE IONIC ORGANIC COMPOUND, METHOD OF PRODUCING THE SAME, AND PHOTORESPONSIVE CARBON NANOTUBE DISPERSANT COMPRISING SAID IONIC ORGANIC COMPOUND | CNTN1, CRY2, CRY1 | ALDH1A1 1651/4885TSHR 2785/4885FOLH1 4855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.